
Loading, please wait...

Loading, please wait...

Liver transplantation remains a life-saving intervention for end-stage liver disease. However, the procedure carries significant perioperative risks. Consequently, clinicians must perform comprehensive preoperative assessments. A recent study highlights how pulmonary function tests (PFTs) play a pivotal role in predicting liver transplant respiratory outcomes. By identifying specific markers, medical teams can better estimate post-transplant survival and respiratory-related mortality.
The research analyzed data from over 700 transplant recipients. Researchers found that lower forced expiratory volume in 1 second (FEV1) independently predicts poorer overall survival. Specifically, a lower FEV1 z-score correlates with a higher risk of post-transplant death. Furthermore, traditional clinical factors like older age and active smoking significantly diminish survival chances. These findings emphasize the necessity of addressing modifiable risk factors before surgery.
Beyond general survival, certain parameters specifically forecast respiratory-related deaths. The study identified the single-breath diffusing capacity of the lung (DLCO SB) as a critical predictor. Notably, patients with a lower DLCO SB z-score face a significantly higher risk of respiratory failure post-transplantation. Additionally, a reduced FEV1/FVC ratio also serves as an independent warning sign. Therefore, a thorough respiratory evaluation allows for tailored postoperative care and better patient monitoring. Similarly, the Liver Transplant Society of India (LTSI) emphasizes evaluating comorbid conditions like hepatopulmonary syndrome to ensure safer transitions.
These results support the routine implementation of PFTs for all liver transplant candidates. Because respiratory complications often contribute to early morbidity, identifying high-risk individuals is essential. Moreover, integrating PFT data with clinical variables enhances the accuracy of prognostic models. Consequently, this proactive approach helps optimize long-term outcomes for patients in India and worldwide.
PFTs help assess a patient’s respiratory fitness. They identify hidden lung issues that might lead to complications or death after the major surgery.
Doctors should focus on DLCO SB and the FEV1/FVC ratio. Lower values in these areas are strong independent predictors of post-transplant respiratory mortality.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Tang LCY et al. Pulmonary function test parameters prior to liver transplantation predict post-transplant survival and respiratory-related death. Liver Transpl. 2026 Feb 24. doi: 10.1097/LVT.0000000000000830. PMID: 41730228.
Li X et al. Preoperative DLCO predicts severe early complications after liver transplantation. Respir Med Res. 2024 Feb 07. doi: 10.1016/j.resmer.2024.101089. PMID: 38657299.
Liver Transplant Society of India (LTSI) Consensus Guidelines: Preoperative Pulmonary Evaluation in Adult Liver Transplant Recipients. J Clin Exp Hepatol. 2023 Jul-Aug;13(4):645-660. doi: 10.1016/j.jceh.2023.01.011.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study identifies pre-transplant PFT parameters, specifically FEV1 and DLCO, as key predictors for post-liver transplant survival and respiratory death....
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today